Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology (CTC-CEC-ADN)

Institut Curie

Status: Completed

Conditions: Solid Tumor, Adult

Treatments: Procedure: Blood sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT02220556

IC 2010-01

Details and patient eligibility

About

Fifteen cohorts will be opened. Each cohort will explore one analysis method and/or tumoral type. Up to 50 patient can be included into each cohort.

Enrollment: 360 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years old or more
• Performance status from 0 to 4
• Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma.
• Informed consent form signed.

Exclusion criteria

• Patient with history of other invasive cancer within 5 years.
• Patient treated for any non-invasive cancer
• Patient individually deprived of liberty or placed under the authority of a tutor
• Geographical condition potentially preventing compliance with the study protocol.

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)